|
In Australia, musculoskeletal diseases are the second most common
cause of presentations to a general practitioner4 and the third
leading cause of health system expenditure, with an estimated total
cost of over $3 billion in 1993-19945 (Box). This compares with an
estimated total cost of $3.5 billion for circulatory diseases, $2.5
billion for respiratory diseases and $1 billion for endocrine
disorders.6 Furthermore, in
1993-1994,1 musculoskeletal diseases
accounted for nearly 300 000 hospital admissions, nearly 15 million
medical services and over 13 million prescriptions.5 Significant
disability due to musculoskeletal disease has been noted in more than
half of people aged over 65 years,7 and is also commonly
self-reported in population samples.8 Indeed, osteoarthritis
(the most common form of arthritis) accounts for over 5% of years lost
due to disability in Australia.9
What is the Bone and Joint Decade and what is its intended impact? One
objective is to create national networks of professional and patient
organisations which will establish their own national goals and
agendas. The desire is to develop a patient "focus", with
individuals living with rheumatic disease being significantly
involved in the process. Some 80 countries have established national
coordinators, and over 20, including Australia, have endorsed the
Decade.
The Decade has four major aims:
- To raise awareness of the
growing burden of musculoskeletal disorders on society;
- To promote prevention of musculoskeletal disorders and empower
patients through education campaigns;
- To advance research on prevention, diagnosis and treatment of
musculoskeletal disorders; and
- To improve diagnosis and treatment of musculoskeletal disorders.
Groups such as the Arthritis Foundation of Australia, the Australian
Rheumatology Association and the Australian Orthopaedic
Association are already actively pursuing some of these aims and will
play major roles in developing activities for the Decade in
Australia.
Although one focus of the Decade may well be on the aged and diseases
causing disability (eg, osteoporosis, osteoarthritis and back
pain), the Decade will also address the increasing problem of
musculoskeletal trauma. This is of particular relevance to young
populations in both developed and developing countries. Much more
information is needed on the epidemiology of trauma, risk factors,
ways of minimising damage to tissues after trauma, and strategies to
enhance rehabilitation. The recently advertised National Health
and Medical Research Council Trauma Research Partnerships
will be helpful in this regard.
The past decade has seen enormously exciting advances in the
management of osteoporosis and in our understanding of the basic
mechanisms of inflammation, which produces so much pain and
disability in diseases such as rheumatoid arthritis. These advances
include an understanding of the role of genetic markers in
osteoporosis, elucidation of risk factors for falls and subsequent
fractures, and development of the bisphosphonates. More recently,
exciting advances have occurred in the therapeutics of
musculoskeletal diseases, previously little changed for decades.
These include the development of monoclonal antibodies to
substances such as tumour necrosis factor, new specific
antirheumatic drugs, and the cyclooxygenase-2 (COX-2) specific
inhibitors, which have the potential to reduce pain and inflammation
without major gastrointestinal adverse reactions.
Musculoskeletal surgery, particularly joint replacement, has
revolutionised the lives of many elderly (and some younger)
Australians. Hip and knee replacements are among the most
cost-effective interventions in medicine, comparing favourably to
coronary bypass surgery and renal dialysis,10 and very significantly
improve the quality of life in patients with a variety of rheumatic
diseases.11 In addition, data
suggesting that osteoarthritis of the knee is related to obesity and
can be alleviated to some extent by weight reduction present a cogent
argument for primary prevention.12
Many musculoskeletal conditions produce chronic pain, which itself
strongly contributes to disability and decreased quality of life.
Strategies to address chronic musculoskeletal pain will also be a
priority of the Decade.
The hope is that the Bone and Joint Decade will focus attention on these
important diseases, demonstrating to healthcare providers that a
relatively modest investment can produce significant benefits. The
Bone and Joint Decade will try to bring together these important
strands of research, education and service to improve the lot of the
millions of Australians who suffer each week from a rheumatic
condition. A meeting of professional groups, patients and patient
organisations and healthcare providers will shortly be convened to
begin planning for the Decade in Australia.
The 1990s were designated the Decade of the Brain, and spawned
enormous interest around the world in the neurosciences, which is now
starting to have significant spin-offs in treatment. It should be
remembered that that Decade began with a significant financial
investment from the United States Congress, while the Bone and Joint
Decade has had no such funding as yet.
This week is National Arthritis Week and professional and patient
groups around Australia will focus attention on these important
chronic and disabling diseases and their impact on society. They
should proceed in the knowledge that there is now a considerable
groundswell of energy worldwide and evidence that, for chronic
rheumatic diseases, something can be done.
Peter M Brooks
Executive Dean, Health Sciences University of Queensland,
Brisbane, QLD
John A L Hart
Clinical Associate Professor of Surgery Monash University,
Melbourne, VIC
and Australian Coordinator of the Bone and Joint Decade
- Hazes JM, Woolf AD. The bone and joint decade 2000-2010. J
Rheumatol 2000; 27: 1-3.
-
Dieppe P. Osteoarthritis. Acta Orthop Scand Suppl 1998;
281: 2-5.
-
Murray JL, Lopez AD, editors. The global burden of disease: a
comprehensive assessment of mortality and disability from
diseases, injuries and risk factors in 1990 and projected to 2020.
Cambridge, Mass: Harvard University Press, 1996.
-
Britt H, Sayer GP, Miller GC, et al. General practice activity in
Australia 1998-1999. Canberra, ACT: Australian Institute of Health
and Welfare, 1999. AIHW Cat No. GEP 2.
-
Mathers C, Penn R. Health system costs of injury, poisoning and
musculo-skeletal disorders in Australia 1993-94. Canberra:
Australian Institute of Health and Welfare, 1999. AIHW Cat No. HWE 12
(Health and Welfare Expenditure Series No. 6).
-
Mathers C. Burden of disease and health system costs of heart
disease, depression and back problems in Australia. Presented at the
National Health and Medical Research Council National Forum.
Canberra; 24 Mar 1998.
-
March LM, Brnabic AJM, Skinner JC, et al. Musculoskeletal
disability among elderly people in the community. Med J Aust
1998; 168: 439-442.
-
Hill CL, Parsons J, Taylor A, Leach G. Health related quality of life
in a population sample with arthritis. J Rheumatol 1999; 26:
2029-2035.
-
Mathers C, Vos T, Stevenson C. The burden of disease and injury in
Australia. Canberra: Australian Institute of Health and Welfare,
1999. AIHW cat. no. PHE 17.
-
Liang MH, Cullen KE, Larson MG, et al. Cost effectiveness of total
joint arthroplasty in osteoarthritis. Arthritis Rheum
1986; 29: 937-943.
-
March LM, Cross MJ, Lapsley H, et al. Outcomes after hip or knee
replacement surgery for osteoarthritis. A prospective cohort study
comparing patients' quality of life before and after surgery with
age-related population norms. Med J Aust 1999; 171: 235-238.
-
Hart DJ, Spector TD. The relationship of obesity, fat
distribution and osteoarthritis in women in the general population.
The Chingford Study. J Rheumatol 1993; 20: 331-335.
©MJA 2000
Make a
comment
Other articles have cited this article:
Peter M Brooks, Michael J Hooper and Richard A Smallwood AO. Bone and joint diseases: prevention and control Med J Aust 2004; 180 (5 Suppl): SS4-SS5. [Bone and Joint Disorders: Prevention and] <http://www.mja.com.au/public/issues/180_05_010304/bro10458_fm.html>
John A L Hart. Joint replacement surgery Med J Aust 2004; 180 (5 Suppl): SS27-SS30. [Bone and Joint Disorders: Prevention and] <http://www.mja.com.au/public/issues/180_05_010304/har10356_fm.html>
Mellick J Chehade and Aleksander Bachorski. Development of the Australian Core Competencies in Musculoskeletal Basic and Clinical Science project — phase 1 Med J Aust 2008; 189 (3): 162-165. [Medical Education] <http://www.mja.com.au/public/issues/189_03_040808/che11371_fm.html>
Readers may print a single copy for personal use. No further
reproduction or distribution of the articles
should proceed without the permission of the publisher. For
permission, contact the
Australasian Medical Publishing Company.
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au>".
<URL: http://www.mja.com.au/>
© 2000 Medical Journal of Australia.
We appreciate
your comments.
|